Clinical Trials Directory

Trials / Completed

CompletedNCT04743154

In-hospital Versus After-discharge Complete Revascularization

In-hospital Versus After-discharge Complete Revascularization in STEMI Patients With Multivessel Disease.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
250 (actual)
Sponsor
Hospital General Universitario de Valencia · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Patients with STEMI and multivessel disease in whom the culprit lesion has been successfully revascularized during prmimary PCI, will be randomized to in-hospital or after-discharge complete revascularization. The purpose of this study is to evaluate the impact of these two different strategies in terms of hospital stay.

Detailed description

STEMI patients with mutivessel disease are, after successful primary angioplasty, randomized 1:1 ratio to either in-hospital complete revascularization or after-discharge complete revascularization strategy. Eligible non-culprit coronary arteries must be \>2.0 mm in diameter and at the discretion of the operator suitable for PCI. Only arteries with angiographically stenoses ≥70% or between ≥50% and \<70 in proximal segments can be randomized. Patients in the in-hospital revascularization group will undergo to non-culprit percutaneous coronary intervention (PCI) at least 24 hours after ST-segment elevation myocardial infarction. On the other hand, patients in the after-discharge group will undergo to non-culprit PCI within 4-6 weeks after STEMI.

Conditions

Interventions

TypeNameDescription
OTHERIn-hospital nonculprit-lesions percutaneous coronary intervention (PCI)To perform percutaneous coronary intervention of non-culprit vessels in a staged procedure during index admission.
OTHERAfter-discharge nonculprit-lesions percutaneous coronary intervention (PCI)To perform percutaneous coronary intervention of non-culprit vessels in a staged procedure after hospital discharge.

Timeline

Start date
2018-01-20
Primary completion
2021-11-25
Completion
2022-12-21
First posted
2021-02-08
Last updated
2023-04-24

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04743154. Inclusion in this directory is not an endorsement.